- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.
According to this latest study, the 2020 growth of Drug Safety and Pharmacovigilance (PV) Software will have significant change from previous year. By the most conservative estimates of global Drug Safety and Pharmacovigilance (PV) Software market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Drug Safety and Pharmacovigilance (PV) Software market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug Safety and Pharmacovigilance (PV) Software market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Drug Safety and Pharmacovigilance (PV) Software, covering the supply chain analysis, impact assessment to the Drug Safety and Pharmacovigilance (PV) Software market size growth rate in several scenarios, and the measures to be undertaken by Drug Safety and Pharmacovigilance (PV) Software companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
On-Premises
Cloud-Based
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Pharma and Biotech Companies
Contract Research Organizations (CROs)
Business Process Outsourcing (BPO) Firms
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
ArisGlobal (US)
Ennov Solutions Inc. (US)
Online Business Applications, Inc. (US)
Oracle Corporation (US)
EXTEDO GmbH (US)
United BioSource Corporation (US)
Sarjen Systems Pvt. Ltd (India)
Sparta Systems, Inc. (US)
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Drug Safety and Pharmacovigilance (PV) Software market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Drug Safety and Pharmacovigilance (PV) Software market by identifying its various subsegments.
Focuses on the key global Drug Safety and Pharmacovigilance (PV) Software players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Drug Safety and Pharmacovigilance (PV) Software with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Drug Safety and Pharmacovigilance (PV) Software submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
1.7 What is the Impact of Covid-19 Outbreak On the Drug Safety and Pharmacovigilance (PV) Software?
1.7.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.7.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.7.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Drug Safety and Pharmacovigilance (PV) Software Market Size in 2020, by Scenario
1.7.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drug Safety and Pharmacovigilance (PV) Software Market Size 2015-2025
2.1.2 Drug Safety and Pharmacovigilance (PV) Software Market Size CAGR by Region
2.2 Drug Safety and Pharmacovigilance (PV) Software Segment by Type
2.2.1 On-Premises
2.2.2 On-Premises
2.3 Drug Safety and Pharmacovigilance (PV) Software Market Size by Type
2.3.1 Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Type (2015-2020)
2.3.2 Global Drug Safety and Pharmacovigilance (PV) Software Market Size Growth Rate by Type (2015-2020)
2.4 Drug Safety and Pharmacovigilance (PV) Software Segment by Application
2.4.1 Pharma and Biotech Companies
2.4.2 Contract Research Organizations (CROs)
2.4.3 Business Process Outsourcing (BPO) Firms
2.4.4 Other
2.5 Drug Safety and Pharmacovigilance (PV) Software Market Size by Application
2.5.1 Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Application (2015-2020)
2.5.2 Global Drug Safety and Pharmacovigilance (PV) Software Market Size Growth Rate by Application (2015-2020)
3 Global Drug Safety and Pharmacovigilance (PV) Software by Players
3.1 Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Players
3.1.1 Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Players (2018-2020)
3.1.2 Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Players (2018-2020)
3.2 Global Drug Safety and Pharmacovigilance (PV) Software Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Drug Safety and Pharmacovigilance (PV) Software by Regions
4.1 Drug Safety and Pharmacovigilance (PV) Software Market Size by Regions
4.2 Americas Drug Safety and Pharmacovigilance (PV) Software Market Size Growth
4.3 APAC Drug Safety and Pharmacovigilance (PV) Software Market Size Growth
4.4 Europe Drug Safety and Pharmacovigilance (PV) Software Market Size Growth
4.5 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size Growth
5 Americas
5.1 Americas Drug Safety and Pharmacovigilance (PV) Software Market Size by Countries
5.2 Americas Drug Safety and Pharmacovigilance (PV) Software Market Size by Type
5.3 Americas Drug Safety and Pharmacovigilance (PV) Software Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Drug Safety and Pharmacovigilance (PV) Software Market Size by Regions
6.2 APAC Drug Safety and Pharmacovigilance (PV) Software Market Size by Type
6.3 APAC Drug Safety and Pharmacovigilance (PV) Software Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Drug Safety and Pharmacovigilance (PV) Software by Countries
7.2 Europe Drug Safety and Pharmacovigilance (PV) Software Market Size by Type
7.3 Europe Drug Safety and Pharmacovigilance (PV) Software Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software by Countries
8.2 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size by Type
8.3 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Drug Safety and Pharmacovigilance (PV) Software Market Forecast
10.1 Global Drug Safety and Pharmacovigilance (PV) Software Market Size Forecast (2021-2025)
10.2 Global Drug Safety and Pharmacovigilance (PV) Software Forecast by Regions
10.2.1 Global Drug Safety and Pharmacovigilance (PV) Software Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Drug Safety and Pharmacovigilance (PV) Software Forecast by Type
10.8 Global Drug Safety and Pharmacovigilance (PV) Software Forecast by Application
11 Key Players Analysis
11.1 ArisGlobal (US)
11.1.1 Company Details
11.1.2 Drug Safety and Pharmacovigilance (PV) Software Product Offered
11.1.3 ArisGlobal (US) Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 ArisGlobal (US) News
11.2 Ennov Solutions Inc. (US)
11.2.1 Company Details
11.2.2 Drug Safety and Pharmacovigilance (PV) Software Product Offered
11.2.3 Ennov Solutions Inc. (US) Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 Ennov Solutions Inc. (US) News
11.3 Online Business Applications, Inc. (US)
11.3.1 Company Details
11.3.2 Drug Safety and Pharmacovigilance (PV) Software Product Offered
11.3.3 Online Business Applications, Inc. (US) Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 Online Business Applications, Inc. (US) News
11.4 Oracle Corporation (US)
11.4.1 Company Details
11.4.2 Drug Safety and Pharmacovigilance (PV) Software Product Offered
11.4.3 Oracle Corporation (US) Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 Oracle Corporation (US) News
11.5 EXTEDO GmbH (US)
11.5.1 Company Details
11.5.2 Drug Safety and Pharmacovigilance (PV) Software Product Offered
11.5.3 EXTEDO GmbH (US) Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 EXTEDO GmbH (US) News
11.6 United BioSource Corporation (US)
11.6.1 Company Details
11.6.2 Drug Safety and Pharmacovigilance (PV) Software Product Offered
11.6.3 United BioSource Corporation (US) Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 United BioSource Corporation (US) News
11.7 Sarjen Systems Pvt. Ltd (India)
11.7.1 Company Details
11.7.2 Drug Safety and Pharmacovigilance (PV) Software Product Offered
11.7.3 Sarjen Systems Pvt. Ltd (India) Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 Sarjen Systems Pvt. Ltd (India) News
11.8 Sparta Systems, Inc. (US)
11.8.1 Company Details
11.8.2 Drug Safety and Pharmacovigilance (PV) Software Product Offered
11.8.3 Sparta Systems, Inc. (US) Drug Safety and Pharmacovigilance (PV) Software Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 Sparta Systems, Inc. (US) News
12 Research Findings and Conclusion
List of Tables
Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Drug Safety and Pharmacovigilance (PV) Software Market Size in 2020, by Scenario
Table 2. COVID-19: Measures to be Undertaken by Drug Safety and Pharmacovigilance (PV) Software Companies
Table 3. Research Methodology
Table 4. Data Source
Table 5. Drug Safety and Pharmacovigilance (PV) Software Market Size CAGR by Region 2015-2025 ($ Millions)
Table 6. Major Players of On-Premises
Table 7. Major Players of Cloud-Based
Table 8. Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2014-2019) ($ Millions)
Table 9. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Type (2015-2020)
Table 10. Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2015-2020) ($ Millions)
Table 11. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Application (2015-2020)
Table 12. Global Drug Safety and Pharmacovigilance (PV) Software Revenue by Players (2018-2020) ($ Millions)
Table 13. Global Drug Safety and Pharmacovigilance (PV) Software Revenue Market Share by Players (2018-2020)
Table 14. Global Drug Safety and Pharmacovigilance (PV) Software Key Players Head office and Products Offered
Table 15. Drug Safety and Pharmacovigilance (PV) Software Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Regions 2015-2020 ($ Millions)
Table 19. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Regions 2015-2020
Table 20. Americas Drug Safety and Pharmacovigilance (PV) Software Market Size by Countries (2015-2020) ($ Millions)
Table 21. Americas Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Countries (2015-2020)
Table 22. Americas Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2015-2020) ($ Millions)
Table 23. Americas Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Type (2015-2020)
Table 24. Americas Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2015-2020) ($ Millions)
Table 25. Americas Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Application (2015-2020)
Table 26. APAC Drug Safety and Pharmacovigilance (PV) Software Market Size by Regions (2015-2020) ($ Millions)
Table 27. APAC Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Regions (2015-2020)
Table 28. APAC Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2015-2020) ($ Millions)
Table 29. APAC Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Type (2015-2020)
Table 30. APAC Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2015-2020) ($ Millions)
Table 31. APAC Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Application (2015-2020)
Table 32. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size by Countries (2015-2020) ($ Millions)
Table 33. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Countries (2015-2020)
Table 34. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2015-2020) ($ Millions)
Table 35. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Type (2015-2020)
Table 36. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2015-2020) ($ Millions)
Table 37. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Application (2015-2020)
Table 38. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size by Countries (2015-2020) ($ Millions)
Table 39. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Countries (2015-2020)
Table 40. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2015-2020) ($ Millions)
Table 41. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Type (2015-2020)
Table 42. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2015-2020) ($ Millions)
Table 43. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Application (2015-2020)
Table 44. Key and Potential Regions of Drug Safety and Pharmacovigilance (PV) Software
Table 45. Key Application and Potential Industries of Drug Safety and Pharmacovigilance (PV) Software
Table 46. Key Challenges of Drug Safety and Pharmacovigilance (PV) Software
Table 47. Key Trends of Drug Safety and Pharmacovigilance (PV) Software
Table 48. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 49. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share Forecast by Regions
Table 50. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Forecast by Type (2021-2025) ($ Millions)
Table 51. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share Forecast by Type (2021-2025)
Table 52. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Forecast by Application (2021-2025) ($ Millions)
Table 53. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share Forecast by Application (2021-2025)
Table 54. ArisGlobal (US) Details, Company Total Revenue (in $ million), Head Office, Drug Safety and Pharmacovigilance (PV) Software Major Market Areas and Its Competitors
Table 55. ArisGlobal (US) Drug Safety and Pharmacovigilance (PV) Software Product Offered
Table 56. ArisGlobal (US) Drug Safety and Pharmacovigilance (PV) Software Revenue and Gross Margin (2018-2020E)
Table 57. ArisGlobal (US) Main Business
Table 58. ArisGlobal (US) Latest Developments
Table 59. Ennov Solutions Inc. (US) Details, Company Total Revenue (in $ million), Head Office, Drug Safety and Pharmacovigilance (PV) Software Major Market Areas and Its Competitors
Table 60. Ennov Solutions Inc. (US) Drug Safety and Pharmacovigilance (PV) Software Product Offered
Table 61. Ennov Solutions Inc. (US) Main Business
Table 62. Ennov Solutions Inc. (US) Drug Safety and Pharmacovigilance (PV) Software Revenue and Gross Margin (2018-2020E)
Table 63. Ennov Solutions Inc. (US) Latest Developments
Table 64. Online Business Applications, Inc. (US) Details, Company Total Revenue (in $ million), Head Office, Drug Safety and Pharmacovigilance (PV) Software Major Market Areas and Its Competitors
Table 65. Online Business Applications, Inc. (US) Drug Safety and Pharmacovigilance (PV) Software Product Offered
Table 66. Online Business Applications, Inc. (US) Main Business
Table 67. Online Business Applications, Inc. (US) Drug Safety and Pharmacovigilance (PV) Software Revenue and Gross Margin (2018-2020E)
Table 68. Online Business Applications, Inc. (US) Latest Developments
Table 69. Oracle Corporation (US) Details, Company Total Revenue (in $ million), Head Office, Drug Safety and Pharmacovigilance (PV) Software Major Market Areas and Its Competitors
Table 70. Oracle Corporation (US) Drug Safety and Pharmacovigilance (PV) Software Product Offered
Table 71. Oracle Corporation (US) Main Business
Table 72. Oracle Corporation (US) Drug Safety and Pharmacovigilance (PV) Software Revenue and Gross Margin (2018-2020E)
Table 73. Oracle Corporation (US) Latest Developments
Table 74. EXTEDO GmbH (US) Details, Company Total Revenue (in $ million), Head Office, Drug Safety and Pharmacovigilance (PV) Software Major Market Areas and Its Competitors
Table 75. EXTEDO GmbH (US) Drug Safety and Pharmacovigilance (PV) Software Product Offered
Table 76. EXTEDO GmbH (US) Main Business
Table 77. EXTEDO GmbH (US) Drug Safety and Pharmacovigilance (PV) Software Revenue and Gross Margin (2018-2020E)
Table 78. EXTEDO GmbH (US) Latest Developments
Table 79. United BioSource Corporation (US) Details, Company Total Revenue (in $ million), Head Office, Drug Safety and Pharmacovigilance (PV) Software Major Market Areas and Its Competitors
Table 80. United BioSource Corporation (US) Drug Safety and Pharmacovigilance (PV) Software Product Offered
Table 81. United BioSource Corporation (US) Main Business
Table 82. United BioSource Corporation (US) Drug Safety and Pharmacovigilance (PV) Software Revenue and Gross Margin (2018-2020E)
Table 83. United BioSource Corporation (US) Latest Developments
Table 84. Sarjen Systems Pvt. Ltd (India) Details, Company Total Revenue (in $ million), Head Office, Drug Safety and Pharmacovigilance (PV) Software Major Market Areas and Its Competitors
Table 85. Sarjen Systems Pvt. Ltd (India) Drug Safety and Pharmacovigilance (PV) Software Product Offered
Table 86. Sarjen Systems Pvt. Ltd (India) Main Business
Table 87. Sarjen Systems Pvt. Ltd (India) Drug Safety and Pharmacovigilance (PV) Software Revenue and Gross Margin (2018-2020E)
Table 88. Sarjen Systems Pvt. Ltd (India) Latest Developments
Table 89. Sparta Systems, Inc. (US) Details, Company Total Revenue (in $ million), Head Office, Drug Safety and Pharmacovigilance (PV) Software Major Market Areas and Its Competitors
Table 90. Sparta Systems, Inc. (US) Drug Safety and Pharmacovigilance (PV) Software Product Offered
Table 91. Sparta Systems, Inc. (US) Main Business
Table 92. Sparta Systems, Inc. (US) Drug Safety and Pharmacovigilance (PV) Software Revenue and Gross Margin (2018-2020E)
Table 93. Sparta Systems, Inc. (US) Latest Developments
List of Figures
Figure 1. Drug Safety and Pharmacovigilance (PV) Software Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Type (2015-2020)
Figure 5. Global On-Premises Market Size Growth Rate
Figure 6. Global Cloud-Based Market Size Growth Rate
Figure 7. Drug Safety and Pharmacovigilance (PV) Software in Pharma and Biotech Companies
Figure 8. Global Drug Safety and Pharmacovigilance (PV) Software Market: Pharma and Biotech Companies (2015-2020) ($ Millions)
Figure 9. Drug Safety and Pharmacovigilance (PV) Software in Contract Research Organizations (CROs)
Figure 10. Global Drug Safety and Pharmacovigilance (PV) Software Market: Contract Research Organizations (CROs) (2015-2020) ($ Millions)
Figure 11. Drug Safety and Pharmacovigilance (PV) Software in Business Process Outsourcing (BPO) Firms
Figure 12. Global Drug Safety and Pharmacovigilance (PV) Software Market: Business Process Outsourcing (BPO) Firms (2015-2020) ($ Millions)
Figure 13. Global Business Process Outsourcing (BPO) Firms YoY Growth ($ Millions)
Figure 14. Drug Safety and Pharmacovigilance (PV) Software in Other
Figure 15. Global Drug Safety and Pharmacovigilance (PV) Software Market: Other (2015-2020) ($ Millions)
Figure 16. Global Other YoY Growth ($ Millions)
Figure 17. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Application in 2019
Figure 18. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Regions 2015-2020
Figure 19. Americas Drug Safety and Pharmacovigilance (PV) Software Market Size 2015-2020 ($ Millions)
Figure 20. APAC Drug Safety and Pharmacovigilance (PV) Software Market Size 2015-2020 ($ Millions)
Figure 21. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size 2015-2020 ($ Millions)
Figure 22. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size 2015-2020 ($ Millions)
Figure 23. Americas Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Countries in 2019
Figure 24. Americas Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Type in 2019
Figure 25. Americas Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Application in 2019
Figure 26. United States Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2015-2020 ($ Millions)
Figure 27. Canada Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2015-2020 ($ Millions)
Figure 28. Mexico Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2015-2020 ($ Millions)
Figure 29. APAC Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Regions in 2019
Figure 30. APAC Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Type in 2019
Figure 31. APAC Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Application in 2019
Figure 32. China Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2015-2020 ($ Millions)
Figure 33. Japan Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2015-2020 ($ Millions)
Figure 34. Korea Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2015-2020 ($ Millions)
Figure 35. Southeast Asia Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2015-2020 ($ Millions)
Figure 36. India Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2015-2020 ($ Millions)
Figure 37. Australia Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2015-2020 ($ Millions)
Figure 38. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Countries in 2019
Figure 39. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Type in 2019
Figure 40. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Application in 2019
Figure 41. Germany Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2015-2020 ($ Millions)
Figure 42. France Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2015-2020 ($ Millions)
Figure 43. UK Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2015-2020 ($ Millions)
Figure 44. Italy Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2015-2020 ($ Millions)
Figure 45. Russia Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2015-2020 ($ Millions)
Figure 46. Spain Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2015-2020 ($ Millions)
Figure 47. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Countries in 2019
Figure 48. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Type in 2019
Figure 49. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size Market Share by Application in 2019
Figure 50. Egypt Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2015-2020 ($ Millions)
Figure 51. South Africa Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2015-2020 ($ Millions)
Figure 52. Israel Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2015-2020 ($ Millions)
Figure 53. Turkey Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2015-2020 ($ Millions)
Figure 54. GCC Countries Drug Safety and Pharmacovigilance (PV) Software Market Size Growth 2015-2020 ($ Millions)
Figure 55. Global Drug Safety and Pharmacovigilance (PV) Software arket Size Forecast (2021-2025) ($ Millions)
Figure 56. Americas Drug Safety and Pharmacovigilance (PV) Software Market Size 2021-2025 ($ Millions)
Figure 57. APAC Drug Safety and Pharmacovigilance (PV) Software Market Size 2021-2025 ($ Millions)
Figure 58. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size 2021-2025 ($ Millions)
Figure 59. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size 2021-2025 ($ Millions)
Figure 60. United States Drug Safety and Pharmacovigilance (PV) Software Market Size 2021-2025 ($ Millions)
Figure 61. Canada Drug Safety and Pharmacovigilance (PV) Software Market Size 2021-2025 ($ Millions)
Figure 62. Mexico Drug Safety and Pharmacovigilance (PV) Software Market Size 2021-2025 ($ Millions)
Figure 63. Brazil Drug Safety and Pharmacovigilance (PV) Software Market Size 2021-2025 ($ Millions)
Figure 64. China Drug Safety and Pharmacovigilance (PV) Software Market Size 2021-2025 ($ Millions)
Figure 65. Japan Drug Safety and Pharmacovigilance (PV) Software Market Size 2021-2025 ($ Millions)
Figure 66. Korea Drug Safety and Pharmacovigilance (PV) Software Market Size 2021-2025 ($ Millions)
Figure 67. Southeast Asia Drug Safety and Pharmacovigilance (PV) Software Market Size 2021-2025 ($ Millions)
Figure 68. India Drug Safety and Pharmacovigilance (PV) Software Market Size 2021-2025 ($ Millions)
Figure 69. Australia Drug Safety and Pharmacovigilance (PV) Software Market Size 2021-2025 ($ Millions)
Figure 70. Germany Drug Safety and Pharmacovigilance (PV) Software Market Size 2021-2025 ($ Millions)
Figure 71. France Drug Safety and Pharmacovigilance (PV) Software Market Size 2021-2025 ($ Millions)
Figure 72. UK Drug Safety and Pharmacovigilance (PV) Software Market Size 2021-2025 ($ Millions)
Figure 73. Italy Drug Safety and Pharmacovigilance (PV) Software Market Size 2021-2025 ($ Millions)
Figure 74. Russia Drug Safety and Pharmacovigilance (PV) Software Market Size 2021-2025 ($ Millions)
Figure 75. Spain Drug Safety and Pharmacovigilance (PV) Software Market Size 2021-2025 ($ Millions)
Figure 76. Egypt Drug Safety and Pharmacovigilance (PV) Software Market Size 2021-2025 ($ Millions)
Figure 77. South Africa Drug Safety and Pharmacovigilance (PV) Software Market Size 2021-2025 ($ Millions)
Figure 78. Israel Drug Safety and Pharmacovigilance (PV) Software Market Size 2021-2025 ($ Millions)
Figure 79. Turkey Drug Safety and Pharmacovigilance (PV) Software Market Size 2021-2025 ($ Millions)
Figure 80. GCC Countries Drug Safety and Pharmacovigilance (PV) Software Market Size 2021-2025 ($ Millions)
Please feel free to write an email to us or to use our electronic ticketing system.
